tiprankstipranks
Pharming Group Nv (PHAR)
NASDAQ:PHAR
US Market
PHAR
Pharming Group
RESEARCH TOOLSreports
Want to see PHAR full AI Analyst Report?

Pharming Group (PHAR) Ratios

221 Followers

Pharming Group Ratios

PHAR's free cash flow for Q1 2026 was €0.91. For the 2026 fiscal year, PHAR's free cash flow was decreased by € and operating cash flow was €0.03. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 2.63 2.59 3.77 4.06 4.65
Quick Ratio
 2.06 2.03 3.02 3.33 3.94
Cash Ratio
 0.47 1.26 0.74 0.79 3.47
Solvency Ratio
 0.11 0.06 0.02 0.02 0.12
Operating Cash Flow Ratio
 0.47 0.43 -0.02 -0.22 0.38
Short-Term Operating Cash Flow Coverage
 6.47 9.38 -0.42 -9.49 12.70
Net Current Asset Value
€ 75.03M€ 76.58M€ 99.52M€ 72.27M€ 56.34M
Leverage Ratios
Debt-to-Assets Ratio
 0.24 0.23 0.28 0.37 0.39
Debt-to-Equity Ratio
 0.43 0.42 0.51 0.78 0.81
Debt-to-Capital Ratio
 0.30 0.29 0.34 0.44 0.45
Long-Term Debt-to-Capital Ratio
 0.26 0.25 0.26 0.38 0.39
Financial Leverage Ratio
 1.82 1.80 1.81 2.12 2.08
Debt Service Coverage Ratio
 0.02 0.76 1.00 1.46 4.52
Interest Coverage Ratio
 0.01 0.91 -0.99 -0.90 3.40
Debt to Market Cap
 0.11 0.08 0.12 0.18 0.15
Interest Debt Per Share
 2.38 1.92 1.76 2.70 2.08
Net Debt to EBITDA
 1.87 -0.99 3.52 11.12 -1.21
Profitability Margins
Gross Profit Margin
88.12%87.90%88.09%89.72%91.46%
EBIT Margin
5.85%5.13%0.08%-2.47%9.89%
EBITDA Margin
9.14%8.12%5.49%4.03%16.31%
Operating Profit Margin
6.36%5.13%-2.90%-2.20%8.87%
Pretax Profit Margin
5.42%3.42%-2.86%-4.90%7.29%
Net Profit Margin
3.37%0.76%-3.98%-4.30%6.65%
Continuous Operations Profit Margin
3.34%0.67%-3.98%-4.30%6.65%
Net Income Per EBT
62.29%22.19%139.44%87.81%91.24%
EBT Per EBIT
85.17%66.52%98.50%222.98%82.20%
Return on Assets (ROA)
2.55%0.57%-2.96%-2.28%3.21%
Return on Equity (ROE)
4.75%1.03%-5.36%-4.82%6.68%
Return on Capital Employed (ROCE)
6.24%5.04%-2.64%-1.40%4.98%
Return on Invested Capital (ROIC)
3.76%0.97%-2.59%-1.21%4.48%
Return on Tangible Assets
3.48%0.78%-3.49%-2.69%3.90%
Earnings Yield
1.29%0.23%-1.77%-1.40%1.50%
Efficiency Ratios
Receivables Turnover
 6.16 6.90 5.92 5.76 8.12
Payables Turnover
 0.42 0.43 3.50 1.57 2.01
Inventory Turnover
 0.68 0.70 0.64 0.44 0.41
Fixed Asset Turnover
 16.00 15.74 12.76 7.33 5.25
Asset Turnover
 0.76 0.75 0.74 0.53 0.48
Working Capital Turnover Ratio
 2.01 1.94 1.34 1.08 0.98
Cash Conversion Cycle
 -264.42 -274.94 532.02 653.18 742.73
Days of Sales Outstanding
 59.28 52.92 61.62 63.41 44.97
Days of Inventory Outstanding
 536.69 519.04 574.57 821.73 879.68
Days of Payables Outstanding
 860.39 846.90 104.17 231.95 181.92
Operating Cycle
 595.97 571.96 636.19 885.13 924.65
Cash Flow Ratios
Operating Cash Flow Per Share
 0.07 0.70 -0.03 -0.26 0.27
Free Cash Flow Per Share
 0.07 0.69 -0.04 -0.29 0.25
CapEx Per Share
 <0.01 0.01 0.01 0.02 0.02
Free Cash Flow to Operating Cash Flow
 0.99 0.98 1.44 1.08 0.91
Dividend Paid and CapEx Coverage Ratio
 74.44 66.66 -2.26 -11.82 11.36
Capital Expenditure Coverage Ratio
 74.44 66.66 -2.26 -11.82 11.36
Operating Cash Flow Coverage Ratio
 0.45 0.43 -0.02 -0.10 0.13
Operating Cash Flow to Sales Ratio
 0.14 0.13 >-0.01 -0.07 0.11
Free Cash Flow Yield
5.66%3.91%-0.39%-2.50%2.25%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 77.45 440.78 -56.60 -71.20 66.58
Price-to-Sales (P/S) Ratio
 2.49 3.34 2.26 3.06 4.43
Price-to-Book (P/B) Ratio
 3.59 4.55 3.03 3.43 4.45
Price-to-Free Cash Flow (P/FCF) Ratio
 17.68 25.55 -258.67 -40.02 44.45
Price-to-Operating Cash Flow Ratio
 18.34 25.17 -373.37 -43.40 40.54
Price-to-Earnings Growth (PEG) Ratio
 0.02 -3.57 -3.28 0.38 -3.92
Price-to-Fair Value
 3.59 4.55 3.03 3.43 4.45
Enterprise Value Multiple
 29.07 40.17 44.60 87.15 25.94
Enterprise Value
 980.93M 1.23B 727.58M 860.79M 869.82M
EV to EBITDA
 29.07 40.17 44.60 87.15 25.94
EV to Sales
 2.66 3.26 2.45 3.51 4.23
EV to Free Cash Flow
 18.89 24.94 -280.81 -45.87 42.47
EV to Operating Cash Flow
 18.64 24.57 -405.33 -49.75 38.73
Tangible Book Value Per Share
 0.19 1.98 2.32 2.25 1.57
Shareholders’ Equity Per Share
 0.36 3.88 3.21 3.33 2.48
Tax and Other Ratios
Effective Tax Rate
 0.38 0.80 -0.39 0.12 0.09
Revenue Per Share
 0.50 5.29 4.31 3.73 2.49
Net Income Per Share
 0.02 0.04 -0.17 -0.16 0.17
Tax Burden
 0.62 0.22 1.39 0.88 0.91
Interest Burden
 0.93 0.67 -34.66 1.99 0.74
Research & Development to Revenue
 0.28 0.00 0.28 0.28 0.26
SG&A to Revenue
 163.58 0.66 0.33 0.33 0.30
Stock-Based Compensation to Revenue
 0.02 0.00 0.04 0.04 0.03
Income Quality
 2.62 17.51 0.21 1.44 1.50
Currency in EUR